Original data study · federal multidistrict litigation

Which mass torts grew fastest? 12 months of federal MDL data

We compared 13 monthly reports from the Judicial Panel on Multidistrict Litigation to see which federal mass-tort dockets gained the most pending actions in a year.

By the People's Justice research team · Published

Data: JPML reports dated , to

Key findings

  1. Pending actions in the Depo-Provera MDL (MDL 3140) rose from 1,225 to 6,413 between the JPML reports dated November 3, 2025, and November 2, 2026, a 424% increase and the largest increase of any federal MDL, both in number and in percentage terms.

    Source: JPML report, November 3, 2025 (PDF); JPML report, November 2, 2026 (PDF)

  2. Three other MDLs with at least 1,000 pending actions grew by more than half over the same 12 months: Bard implanted port catheter (MDL 3081, up 104% to 4,345), social media adolescent addiction (MDL 3047, up 98% to 4,309) and Uber passenger sexual assault (MDL 3084, up 63% to 4,548), according to the same JPML reports.

    Source: JPML report, November 3, 2025 (PDF); JPML report, November 2, 2026 (PDF)

  3. Across all federal MDLs, pending actions rose 3.5%, from 197,981 to 204,987, and the number of MDL dockets went from 157 to 164 (27 MDLs were added to the report and 20 were no longer listed) between the JPML reports dated November 3, 2025, and November 2, 2026.

    Source: JPML report, November 3, 2025 (PDF); JPML report, November 2, 2026 (PDF)

  4. One MDL, Johnson & Johnson talcum powder (MDL 2738), holds 69,376 of the 204,987 actions pending in federal MDLs, about one in three (33.8%), according to the JPML report dated November 2, 2026.

    Source: JPML report, November 2, 2026 (PDF)

  5. MDLs the JPML classifies as products liability make up 65 of 164 pending MDL dockets (39.6%) but hold 94.0% of all pending MDL actions (192,725), according to the JPML's November 2, 2026 reports by actions pending and by MDL type.

    Source: JPML report, November 2, 2026 (PDF); JPML report by MDL type, November 2, 2026 (PDF)

These are counts of civil actions in federal MDLs, not counts of people. A pending count rises when actions are filed in or transferred to an MDL and falls when actions are dismissed, settled, remanded or otherwise closed. It does not measure injuries, the strength of any claim or how a case will turn out. Read the limits.

Largest 12-month increases in pending MDL actions

Horizontal bar chart of the 8 largest increases in pending actions among federal MDLs between the JPML reports dated November 3, 2025, and November 2, 2026. Depo-Provera (MDL 3140): +5,188, from 1,225 to 6,413; Bard implanted port catheter (MDL 3081): +2,218, from 2,127 to 4,345; Johnson & Johnson talcum powder (MDL 2738): +2,147, from 67,229 to 69,376; Social media adolescent addiction (MDL 3047): +2,137, from 2,172 to 4,309; Hair relaxer (MDL 3060): +2,020, from 10,723 to 12,743; Uber passenger sexual assault (MDL 3084): +1,765, from 2,783 to 4,548; GLP-1 receptor agonist (MDL 3094): +1,168, from 2,914 to 4,082; Paragard IUD (MDL 2974): +446, from 3,658 to 4,104. Source: Judicial Panel on Multidistrict Litigation.
The 8 MDLs, among those listed in both reports, whose pending actions grew the most between November 3, 2025, to November 2, 2026. Labels give the change and the starting and ending counts. Every value also appears in the table of large MDLs below. Chart image (1600px PNG) · portrait (720px PNG)

Monthly pending actions in the four fastest-growing large MDLs

Four line charts on the same zero-based scale showing pending actions in each monthly JPML report from Nov '25 to Nov '26. Depo-Provera (MDL 3140): 1,225, 1,470, 1,752, 2,098, 3,099, 3,490, 3,769, 5,508, 5,830, 6,294, 6,403, 6,412, 6,413; Bard implanted port catheter (MDL 3081): 2,127, 2,463, 2,545, 2,674, 2,828, 3,044, 3,187, 3,376, 3,564, 3,734, 3,734, 4,140, 4,345; Social media adolescent addiction (MDL 3047): 2,172, 2,191, 2,243, 2,325, 2,407, 2,465, 2,527, 2,664, 2,893, 3,137, 3,208, 3,824, 4,309; Uber passenger sexual assault (MDL 3084): 2,783, 2,949, 3,078, 3,188, 3,291, 3,391, 3,437, 3,571, 3,940, 4,397, 4,588, 4,916, 4,548. Source: Judicial Panel on Multidistrict Litigation.
Pending actions in each monthly JPML report for the four MDLs with at least 1,000 pending actions that grew fastest in percentage terms. All four panels share one zero-based scale. Most of the Depo-Provera growth came earlier in the year: its count was 6,294 in the August 3, 2026, report and 6,413 in the November 2, 2026, report. Chart image (1600px PNG) · portrait (720px PNG)
Pending actions in each monthly JPML report, Nov '25 to Nov '26, for the four fastest-growing large MDLs
JPML report dateDepo-Provera (MDL 3140)Bard implanted port catheter (MDL 3081)Social media adolescent addiction (MDL 3047)Uber passenger sexual assault (MDL 3084)
November 3, 20251,2252,1272,1722,783
December 2, 20251,4702,4632,1912,949
January 5, 20261,7522,5452,2433,078
February 2, 20262,0982,6742,3253,188
March 2, 20263,0992,8282,4073,291
April 1, 20263,4903,0442,4653,391
May 1, 20263,7693,1872,5273,437
June 1, 20265,5083,3762,6643,571
July 1, 20265,8303,5642,8933,940
August 3, 20266,2943,7343,1374,397
September 1, 20266,4033,7343,2084,588
October 1, 20266,4124,1403,8244,916
November 2, 20266,4134,3454,3094,548

Every MDL with 1,000 or more pending actions

Ordered by pending actions in the November 2, 2026 report. Change compares the same MDL number in the November 3, 2025 report. The CSV has every MDL in either report.

MDLs with at least 1,000 pending actions on November 2, 2026, with 12-month change
MDLJPML titlePending, Nov '25Pending, Nov '26ChangeChange (%)
2738IN RE: Johnson & Johnson Talcum Powder Products Marketing, Sales Practices and Products Liability Litigation67,22969,376+2,147+3%
2846IN RE: Davol, Inc./C.R. Bard, Inc., Polypropylene Hernia Mesh Products Liability Litigation23,93223,299−633−3%
2873IN RE: Aqueous Film-Forming Foams Products Liability Litigation15,24915,270+21+0.1%
3060IN RE: Hair Relaxer Marketing, Sales Practices, and Products Liability Litigation10,72312,743+2,020+19%
2789IN RE: Proton-Pump Inhibitor Products Liability Litigation (No. II)11,33111,404+73+0.6%
2666IN RE: Bair Hugger Forced Air Warming Devices Products Liability Litigation8,7578,414−343−4%
3004IN RE: Paraquat Products Liability Litigation6,4336,635+202+3%
2570IN RE: Cook Medical, Inc., IVC Filters Marketing, Sales Practices and Products Liability Litigation6,9696,467−502−7%
3140IN RE: Depo-Provera (Depot Medroxyprogesterone Acetate) Products Liability Litigation1,2256,413+5,188+424%
3084IN RE: Uber Technologies, Inc., Passenger Sexual Assault Litigation2,7834,548+1,765+63%
3081IN RE: Bard Implanted Port Catheter Products Liability Litigation2,1274,345+2,218+104%
3047IN RE: Social Media Adolescent Addiction/Personal Injury Products Liability Litigation2,1724,309+2,137+98%
2974IN RE: Paragard IUD Products Liability Litigation3,6584,104+446+12%
3094IN RE: Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) Products Liability Litigation2,9144,082+1,168+40%
2804IN RE: National Prescription Opiate Litigation2,9652,877−88−3%
3029IN RE: Covidien Hernia Mesh Products Liability Litigation (No. II)2,2012,486+285+13%
3092IN RE: Suboxone (Buprenorphine/Naloxone) Film Products Liability Litigation1,8712,016+145+8%
3044IN RE: Exactech Polyethylene Orthopedic Products Liability Litigation1,8381,83800%
2875IN RE: Valsartan, Losartan, and Irbesartan Products Liability Litigation1,3681,422+54+4%
2921IN RE: Allergan Biocell Textured Breast Implant Products Liability Litigation1,4771,370−107−7%

Largest declines

A falling count can follow dismissals, settlements, remands or other closings. It does not show that anyone was paid or that the litigation ended.

MDLs with the largest decreases in pending actions between November 3, 2025, to November 2, 2026
MDLJPML titlePending, Nov '25Pending, Nov '26Change
2741IN RE: Roundup Products Liability Litigation4,490916−3,574
2740IN RE: Taxotere (Docetaxel) Products Liability Litigation2,9886−2,982
2924IN RE: Zantac (Ranitidine) Products Liability Litigation1,812806−1,006
2848IN RE: Zostavax (Zoster Vaccine Live) Products Liability Litigation8260−826
2846IN RE: Davol, Inc./C.R. Bard, Inc., Polypropylene Hernia Mesh Products Liability Litigation23,93223,299−633

Pending MDL actions by JPML docket type

Types are the JPML's own categories from its November 2, 2026 report by MDL type. Shares are of all 164 dockets and 204,987 pending actions in the report.

Pending MDL dockets and actions by JPML docket type on November 2, 2026
JPML docket typeDocketsShare of docketsPending actionsShare of pending actions
Products Liability6539.6%192,72594.0%
Miscellaneous159.1%8,5884.2%
Antitrust3823.2%1,2150.6%
Data Breach and Consumer Privacy2012.2%1,0860.5%
Sales Practices95.5%6420.3%
Common Disaster31.8%4090.2%
Intellectual Property74.3%1770.1%
Securities42.4%90<0.1%
Air Disaster21.2%49<0.1%
Employment Practices10.6%6<0.1%

Methodology and limits

Sources. The JPML's monthly Pending MDL Dockets reports “by actions pending” for the 13 report dates from November 3, 2025, to November 2, 2026, and the same-date reports “by MDL type.” We downloaded every file from jpml.uscourts.gov on . The JPML's listing page links only the current month; earlier reports remain at the addresses listed below.

Extraction and checks. We converted each PDF to text and read every row's district, judge, MDL number, title, pending actions and total actions. For every report, the number of rows equals the report's docket total, the pending and total actions add up to the report's printed totals, and all eight size-range summaries recompute from the rows. Every MDL in each report also appears in that day's report by MDL type. The 5 months already published in our MDL Monitor (July 2026 to November 2026) parse to exactly the released rows.

Measures. Change is an MDL's pending actions in the November 2, 2026 report minus its pending actions in the November 3, 2025 report, for MDL numbers listed in both. Percentage change divides that difference by the earlier count; findings round it to the nearest whole percent and round shares to one decimal place. A “large” MDL has at least 1,000 pending actions in the latest report. MDLs that are new in the latest report have no 12-month change, and MDLs no longer listed count only toward the earlier report's totals. Short names such as “Depo-Provera” abbreviate the JPML titles, which the tables and CSVs give in full.

Limits. The JPML counts civil actions, not plaintiffs; one action can include more than one plaintiff. A pending count is net of new filings, transfers and closings, so it does not show how many actions were filed. The reports cover federal MDLs only; related cases in state courts are not counted. Report dates fall on the first business days of each month and are not evenly spaced. We do not compare total (historical) actions across the window: they jump when MDL 2885 first appears in the March 2, 2026 report with 391,222 historical actions.

Reproduce it. The scripts in scripts/data-studies/2026-11-mdl-trends/ of our site repository rebuild the data from the PDFs (checking each file's SHA-256), recompute every number on this page and render the charts. A test recomputes the headline findings from the archived reports.

These are the JPML's numbers and our arithmetic. They are not legal advice, estimates or predictions. People's Justice is a legal-information publisher and is not a law firm. See our publishing methodology and corrections process.

Source reports

Cite, embed or republish

You may republish these charts and data, free of charge, under Creative Commons Attribution 4.0. Credit the Judicial Panel on Multidistrict Litigation as the original source and People's Justice for the analysis, link to this page, and say if you changed anything. The license does not imply JPML endorsement. “Free” here describes the license; it is not an offer of legal services. More terms and logos are in our press and data kit.

Citation

People's Justice research team. "Which mass torts grew fastest? 12 months of federal MDL data." People's Justice, November 5, 2026. Data: Judicial Panel on Multidistrict Litigation, Pending MDL Dockets by Actions Pending, reports dated November 3, 2025, to November 2, 2026. https://peoplesjustice.info/data/mdl-growth-2026. Licensed CC BY 4.0.

Embed: largest 12-month increases in pending MDL actions

Paste this HTML into your page. The image is served from our site; you may also download it and host it yourself with the same credit.

<figure style="margin:0"><img src="https://peoplesjustice.info/data/mdl-growth-2026/charts/largest-increases.png" alt="Horizontal bar chart of the 8 largest increases in pending actions among federal MDLs between the JPML reports dated November 3, 2025, and November 2, 2026. Depo-Provera (MDL 3140): +5,188, from 1,225 to 6,413; Bard implanted port catheter (MDL 3081): +2,218, from 2,127 to 4,345; Johnson &amp; Johnson talcum powder (MDL 2738): +2,147, from 67,229 to 69,376; Social media adolescent addiction (MDL 3047): +2,137, from 2,172 to 4,309; Hair relaxer (MDL 3060): +2,020, from 10,723 to 12,743; Uber passenger sexual assault (MDL 3084): +1,765, from 2,783 to 4,548; GLP-1 receptor agonist (MDL 3094): +1,168, from 2,914 to 4,082; Paragard IUD (MDL 2974): +446, from 3,658 to 4,104. Source: Judicial Panel on Multidistrict Litigation." width="1600" height="900" style="max-width:100%;height:auto"><figcaption style="font-size:12px">Chart: <a href="https://peoplesjustice.info/data/mdl-growth-2026" rel="nofollow">People's Justice</a>, CC BY 4.0. Data: Judicial Panel on Multidistrict Litigation.</figcaption></figure>

Embed: monthly pending actions in the four fastest-growing large MDLs

Paste this HTML into your page. The image is served from our site; you may also download it and host it yourself with the same credit.

<figure style="margin:0"><img src="https://peoplesjustice.info/data/mdl-growth-2026/charts/monthly-growth.png" alt="Four line charts on the same zero-based scale showing pending actions in each monthly JPML report from Nov '25 to Nov '26. Depo-Provera (MDL 3140): 1,225, 1,470, 1,752, 2,098, 3,099, 3,490, 3,769, 5,508, 5,830, 6,294, 6,403, 6,412, 6,413; Bard implanted port catheter (MDL 3081): 2,127, 2,463, 2,545, 2,674, 2,828, 3,044, 3,187, 3,376, 3,564, 3,734, 3,734, 4,140, 4,345; Social media adolescent addiction (MDL 3047): 2,172, 2,191, 2,243, 2,325, 2,407, 2,465, 2,527, 2,664, 2,893, 3,137, 3,208, 3,824, 4,309; Uber passenger sexual assault (MDL 3084): 2,783, 2,949, 3,078, 3,188, 3,291, 3,391, 3,437, 3,571, 3,940, 4,397, 4,588, 4,916, 4,548. Source: Judicial Panel on Multidistrict Litigation." width="1600" height="900" style="max-width:100%;height:auto"><figcaption style="font-size:12px">Chart: <a href="https://peoplesjustice.info/data/mdl-growth-2026" rel="nofollow">People's Justice</a>, CC BY 4.0. Data: Judicial Panel on Multidistrict Litigation.</figcaption></figure>

About this study

Analysis and charts by the People's Justice research team, from public JPML records only. No outside experts were interviewed and no figures were estimated. We connect people with law firms, who may pay us for those connections; read how People's Justice makes money. Journalists can find our other datasets, logos and contact route in the press and data kit.